CDKN1A and cancer: ADR treatment induced major p53 targets, p21/CDKN1A and MDM2 mRNA, in wild-type p53 cells, whereas the mRNA expression levels were maintained at low levels in cancer cells harboring a p53 mutation, regardless of the ADR treatment (Supplementary Figure S2A).